HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SENSCIS™ trial investigators Selected Research

Fibrosis (Cirrhosis)

9/2017Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


SENSCIS™ trial investigators Research Topics

Disease

1Fibrosis (Cirrhosis)
09/2017
1Rheumatic Diseases (Rheumatism)
09/2017
1Systemic Scleroderma (Systemic Sclerosis)
09/2017
1Interstitial Lung Diseases (Interstitial Lung Disease)
09/2017
1Idiopathic Pulmonary Fibrosis
09/2017

Drug/Important Bio-Agent (IBA)

1nintedanibIBA
09/2017
1Tyrosine Kinase InhibitorsIBA
09/2017
1Carbon MonoxideIBA
09/2017